- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05007314
Biocriminology and the Adjudication of Criminal Responsibility: Is There a Consensus Among Scientists' Verdicts?
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
In this study, closely inspired by the paradigms of Berryessa, Coppola, and Salvato, perspectives on punishment based on psychobiological explanations of behaviour are assessed, aiming to understand how scientists with knowledge of human psychobiology versus lay people (of similar educational level) interpret offending behaviour. Human-science is contrasted to natural-science/arts graduates because the former have been exposed to and may possess scientific knowledge that shapes their understanding of behaviour, their views, and potential (essentialist) biases. In contrast, non-scientists have been found to possess scientific misconceptions that can impact their sentencing decisions. This leads to the question whether scientists may draw different judgements based on their professional knowledge and experience with psychological phenomena. If indeed scientists with greater insight on human behaviour are found to hold less punitive views on punishment and rehabilitation, that has important implications for criminal justice systems that rely on lay peoples' understanding of science.
One hundred sixty participants who completed all study procedures (2 main groups of 80 participants) will be surveyed. A sample size calculation was performed using G*Power version 3.1.9.4, based on Berryessa and colleagues who conducted a similar survey study in 2021 with comparable outcome measures and analyses. The required effect size is based upon approximately 3-4 outcome measures. The primary research question is between-groups, while secondary ones include within groups measures. Based on the power analysis, a sample of 160 participants will be targeted, which is enough for sufficient power for f = 0.25, power = 0.80, df = 4, for 2 different groups.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
South Holland
-
Leiden, South Holland, Pays-Bas, 2333 AK
- Leiden University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Aged between 18 and 65
- Holding a university diploma or equivalent
Exclusion Criteria:
- Participants who did not complete the survey (appropriately) will be excluded
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Human Science
Arm 1 will include university graduates that hold at least a science undergraduate degree (or equivalent) in human science, including psychology, neuroscience, human biology, or medicine.
|
Participants in each of the two main groups see a case with and a case without a neurobiological explanation for criminal offending.
|
Comparateur actif: Natural or non-science
Arm 2 will include university graduates from non-human or non-scientific fields such as engineering, history, language studies, or law.
|
Participants in each of the two main groups see a case with and a case without a neurobiological explanation for criminal offending.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Sentencing severity on 5-point questionnaire
Délai: Immediately after case presentation, an average of 1 minute.
|
This is the primary outcome measure of attitudes towards sentencing, measured via a questionnaire on a visual analogue scale from 1 (only treatment) to 5 (more than 5 years in prison)
|
Immediately after case presentation, an average of 1 minute.
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 2021-07-16-D.S.V.-V2-3332
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Délai de partage IPD
Critères d'accès au partage IPD
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- ANALYTIC_CODE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .